Related Experiment Videos
Cephalexin rash in infectious mononucleosis
1Loyola University Medical Center, Division of Dermatology, Maywood, Illinois 60153, USA.
Abstract:
The ampicillin rash occurring in cases of infectious mononucleosis is well documented. Similar phenomena have also been observed with other antibiotics. The case of a patient with infectious mononucleosis treated with cephalexin who later showed a rash is presented and the previous literature is reviewed. The rash seen in this patient, who was treated with cephalexin, may be similar to the rash seen with ampicillin treatment of patients with infectious mononucleosis. The mechanism by which these eruptions occur is not completely understood, although there are many interesting theories. Perhaps rashes during infectious mononucleosis in association with other antibiotics are actually more common, but just not recognized. A heightened awareness of this possibility may therefore lead to recognition of more cases and further understanding of this entity.
Insights
A rash associated with infectious mononucleosis (mono) can occur with cephalexin, similar to ampicillin. Increased awareness may help identify more cases and understand antibiotic-induced rashes in mono patients.
Area of Science:
- Infectious Diseases
- Dermatology
- Pharmacology
Background:
- Infectious mononucleosis (mono) is a common viral illness.
- Ampicillin-induced rash in mono patients is a well-documented phenomenon.
- Other antibiotics have also been anecdotally linked to similar rashes.
Observation:
- A case of infectious mononucleosis presenting with a rash after cephalexin treatment is described.
- The patient's rash shares clinical similarities with the ampicillin rash in mono.
- Previous literature on antibiotic-associated rashes in mono is reviewed.
Findings:
- Cephalexin, like ampicillin, may precipitate a rash in patients with infectious mononucleosis.
- The exact mechanism underlying these antibiotic-induced eruptions in mono remains unclear.
- Hypotheses suggest these reactions might be more common than currently recognized.
Implications:
- Heightened clinical awareness of cephalexin-induced rash in mono is warranted.
- Further case recognition could enhance understanding of antibiotic-associated dermatological reactions in mono.
- This may lead to improved diagnostic and management strategies for patients with infectious mononucleosis.